Katherine Janeway, M.D., Dana-Farber Cancer Institute (IMAGE)

Dana-Farber Cancer Institute

Katherine Janeway, M.D., Dana-Farber Cancer Institute

Caption

Dr. Katherine Janeway led a study showing clinical genomic sequencing is feasible in pediatric oncology and can be used to recommend therapy or pinpoint diagnosis in children with solid tumors.

Credit

Dana-Farber Cancer Institute

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.